Top ▲
Target id: 1965
Nomenclature: cyclin dependent kinase 12
Abbreviated Name: CDK12
Family: CRK7 subfamily
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 1490 | 17q12 | CDK12 | cyclin dependent kinase 12 | |
Mouse | - | 1484 | 11 61.75 cM | Cdk12 | cyclin dependent kinase 12 | |
Rat | - | 1484 | 10q31 | Cdk12 | cyclin-dependent kinase 12 |
Previous and Unofficial Names |
CDC2 related protein kinase 7 | cell division cycle 2-related protein kinase 7 | CRK7 | CRKR |
Database Links | |
Alphafold | Q9NYV4 (Hs), Q14AX6 (Mm), Q3MJK5 (Rn) |
BRENDA | 2.7.11.22, 2.7.11.23 |
ChEMBL Target | CHEMBL3559692 (Hs) |
Ensembl Gene | ENSG00000167258 (Hs), ENSMUSG00000003119 (Mm), ENSRNOG00000006000 (Rn), ENSRNOG00000028430 (Rn) |
Entrez Gene | 51755 (Hs), 69131 (Mm), 192350 (Rn) |
Human Protein Atlas | ENSG00000167258 (Hs) |
KEGG Enzyme | 2.7.11.22, 2.7.11.23 |
KEGG Gene | hsa:51755 (Hs), mmu:69131 (Mm), rno:192350 (Rn) |
OMIM | 615514 (Hs) |
Pharos | Q9NYV4 (Hs) |
RefSeq Nucleotide | NM_016507 (Hs), NM_001109626 (Mm), NM_001033867 (Rn) |
RefSeq Protein | NP_057591 (Hs), NP_001103096 (Mm), NP_001029039 (Rn) |
UniProtKB | Q9NYV4 (Hs), Q14AX6 (Mm), Q3MJK5 (Rn) |
Wikipedia | CDK12 (Hs) |
Enzyme Reaction | ||||||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
General Comments |
Mutations in CDK12 that have been found in tumours and pharmacological CDK12 inhibition sensitise cancer cells to DNA-damaging reagents and DNA-repair inhibitors. This selective CDK12 inhibitors are being investigated for potential oncology efficacy. CDK12 inhibitor 2 is a compound that is a suitable tool for studying the effects of CDK12 inhibition in RNA biology and the role of this mechanism in inducing cancer cell synthetic lethality. CDK12 inhibitor 2 selectively inhibits CDK12 and the closely related CDK13 over other C-terminal domain serine kinases [1]. |
1. Ito M, Tanaka T, Toita A, Uchiyama N, Kokubo H, Morishita N, Klein MG, Zou H, Murakami M, Kondo M et al.. (2018) Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors. J Med Chem, 61 (17): 7710-7728. [PMID:30067358]
2. Marineau JJ, Hamman KB, Hu S, Alnemy S, Mihalich J, Kabro A, Whitmore KM, Winter DK, Roy S, Ciblat S et al.. (2022) Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7. J Med Chem, 65 (2): 1458-1480. [PMID:34726887]
CRK7 subfamily: cyclin dependent kinase 12. Last modified on 12/01/2022. Accessed on 15/09/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=1965.